dc.contributor.author
Frombach, Janna
dc.contributor.author
Rancan, Fiorenza
dc.contributor.author
Kübrich, Katharina
dc.contributor.author
Schumacher, Fabian
dc.contributor.author
Unbehauen, Michael
dc.contributor.author
Blume-Peytavi, Ulrike
dc.contributor.author
Haag, Rainer
dc.contributor.author
Kleuser, Burkhard
dc.contributor.author
Sabat, Robert
dc.contributor.author
Wolk, Kerstin
dc.contributor.author
Vogt, Annika
dc.date.accessioned
2021-01-28T13:00:24Z
dc.date.available
2021-01-28T13:00:24Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/29375
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-29121
dc.description.abstract
Standard experimental set-ups for the assessment of skin penetration are typically performed on skin explants with an intact skin barrier or after a partial mechanical or chemical perturbation of the stratum corneum, but they do not take into account biochemical changes. Among the various pathological alterations in inflamed skin, aberrant serine protease (SP) activity directly affects the biochemical environment in the superficial compartments, which interact with topically applied formulations. It further impacts the skin barrier structure and is a key regulator of inflammatory mediators. Herein, we used short-term cultures of ex vivo human skin treated with trypsin and plasmin as inflammatory stimuli to assess the penetration and biological effects of the anti-inflammatory drug dexamethasone (DXM), encapsulated in core multishell-nanocarriers (CMS-NC), when compared to a standard cream formulation. Despite a high interindividual variability, the combined pretreatment of the skin resulted in an average 2.5-fold increase of the transepidermal water loss and swelling of the epidermis, as assessed by optical coherence tomography, as well as in a moderate increase of a broad spectrum of proinflammatory mediators of clinical relevance. The topical application of DXM-loaded CMS-NC or DXM standard cream revealed an increased penetration into SP-treated skin when compared to untreated control skin with an intact barrier. Both formulations, however, delivered sufficient amounts of DXM to effectively suppress the production of interleukin-6 (IL-6), interleukin-8 (IL-8) and Thymic Stromal Lymphopoietin (TSLP). In conclusion, we suggest that the herein presented ex vivo inflammatory skin model is functional and could improve the selection of promising drug delivery strategies for anti-inflammatory compounds at early stages of development. View Full-Text
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
skin barrier
en
dc.subject
skin barrier
en
dc.subject
skin barrier
en
dc.subject
drug delivery
en
dc.subject
nanotechnology
en
dc.subject
core-multi shell nanostructure
en
dc.subject.ddc
500 Naturwissenschaften und Mathematik::540 Chemie::547 Organische Chemie
dc.title
Serine Protease-Mediated Cutaneous Inflammation
dc.type
Wissenschaftlicher Artikel
dc.title.subtitle
Characterization of an Ex Vivo Skin Model for the Assessment of Dexamethasone-Loaded Core Multishell-Nanocarriers
dcterms.bibliographicCitation.articlenumber
862
dcterms.bibliographicCitation.doi
10.3390/pharmaceutics12090862
dcterms.bibliographicCitation.journaltitle
Pharmaceutics
dcterms.bibliographicCitation.number
9
dcterms.bibliographicCitation.originalpublishername
MDPI
dcterms.bibliographicCitation.volume
12
dcterms.bibliographicCitation.url
https://doi.org/10.3390/pharmaceutics12090862
refubium.affiliation
Biologie, Chemie, Pharmazie
refubium.affiliation.other
Institut für Chemie und Biochemie
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dc.identifier.epub
1999-4923